RECURRENT GLIOMA
Clinical trials for RECURRENT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain cancer patients with rare gene fusion
Disease control Recruiting nowThis study tests a drug called erdafitinib in 30 adults with a specific type of brain tumor (glioma) that has returned or is growing. The tumor must have a particular gene change (FGFR-TACC fusion) and lack another common mutation (IDH-wild type). The drug works by blocking a fau…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New Four-in-One antibody takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called GNC-039 in people with advanced solid tumors, including a type of brain cancer called glioma, that have come back or spread. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 60…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control Recruiting nowThis early-phase study tests a new treatment called CARv3-TEAM-E T cells for people with glioblastoma, a fast-growing brain cancer that has come back. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack the tumor. The main goals are to …
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Brain tumor care from your couch: new app trial launches
Knowledge-focused Recruiting nowThis trial tests whether a mobile app can help people with glioma (a type of brain tumor) receive their cancer treatment and monitoring at home instead of traveling to a specialist center. The study will enroll 120 adults who are starting or continuing systemic therapy. The main …
Matched conditions: RECURRENT GLIOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC